MADRIGAL PHARMACEUTICALS INC's ticker is MDGL and the CUSIP is 558868105. A total of 142 filers reported holding MADRIGAL PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 1.87 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297,776 | -26.5% | 2,039 | +16.2% | 0.00% | -50.0% |
| Q2 2023 | $405,405 | +2.5% | 1,755 | +7.5% | 0.00% | 0.0% |
| Q1 2023 | $395,611 | -11.4% | 1,633 | +6.1% | 0.00% | 0.0% |
| Q4 2022 | $446,695 | +329.5% | 1,539 | -3.4% | 0.00% | +100.0% |
| Q3 2022 | $104,000 | -8.8% | 1,593 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $114,000 | -28.8% | 1,593 | -2.0% | 0.00% | 0.0% |
| Q1 2022 | $160,000 | +49.5% | 1,626 | +29.2% | 0.00% | 0.0% |
| Q4 2021 | $107,000 | +7.0% | 1,259 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $100,000 | -18.7% | 1,259 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $123,000 | -16.3% | 1,259 | 0.0% | 0.00% | 0.0% |
| Q1 2021 | $147,000 | +5.0% | 1,259 | 0.0% | 0.00% | 0.0% |
| Q4 2020 | $140,000 | -6.0% | 1,259 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $149,000 | +4.2% | 1,259 | 0.0% | 0.00% | 0.0% |
| Q2 2020 | $143,000 | +320.6% | 1,259 | +150.8% | 0.00% | – |
| Q1 2020 | $34,000 | -26.1% | 502 | 0.0% | 0.00% | – |
| Q4 2019 | $46,000 | +7.0% | 502 | 0.0% | 0.00% | – |
| Q3 2019 | $43,000 | -18.9% | 502 | 0.0% | 0.00% | – |
| Q2 2019 | $53,000 | -15.9% | 502 | 0.0% | 0.00% | -100.0% |
| Q1 2019 | $63,000 | +10.5% | 502 | 0.0% | 0.00% | 0.0% |
| Q4 2018 | $57,000 | -46.7% | 502 | 0.0% | 0.00% | 0.0% |
| Q3 2018 | $107,000 | -23.6% | 502 | 0.0% | 0.00% | 0.0% |
| Q2 2018 | $140,000 | – | 502 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 77,657 | $11,342 | 8.78% |
| University of Wisconsin Foundation | 40,133 | $5,861,023 | 6.72% |
| Paulson & Co. | 500,000 | $73,020,000 | 6.53% |
| TCG Crossover Management, LLC | 179,917 | $26,275,079 | 3.87% |
| Avoro Capital Advisors LLC | 1,555,000 | $227,092,200 | 3.54% |
| Affinity Asset Advisors, LLC | 85,000 | $12,413,400 | 3.49% |
| Ghost Tree Capital, LLC | 57,500 | $8,397,300 | 2.76% |
| Lynwood Capital Management Inc. | 5,000 | $730,200 | 1.92% |
| MPM BioImpact LLC | 40,859 | $5,967,048 | 1.59% |
| Tri Locum Partners LP | 33,761 | $4,930,456 | 1.58% |